Northeast Financial Consultants’s Korro Bio KRRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-857
| Closed | -$14.8K | – | 292 |
|
|
2023
Q2 | $14.8K | Sell |
857
-60
| -7% | -$1.04K | ﹤0.01% | 287 |
|
|
2023
Q1 | $23.1K | Hold |
917
| – | – | ﹤0.01% | 313 |
|
|
2022
Q4 | $176K | Hold |
917
| – | – | 0.01% | 306 |
|
|
2022
Q3 | $82K | Hold |
917
| – | – | 0.01% | 326 |
|
|
2022
Q2 | $69K | Hold |
917
| – | – | ﹤0.01% | 321 |
|
|
2022
Q1 | $97K | Buy |
917
+600
| +189% | +$63.5K | 0.01% | 380 |
|
|
2021
Q4 | $81K | Sell |
317
-510
| -62% | -$130K | ﹤0.01% | 352 |
|
|
2021
Q3 | $292K | Hold |
827
| – | – | 0.02% | 287 |
|
|
2021
Q2 | $412K | Buy |
827
+117
| +16% | +$58.3K | 0.03% | 240 |
|
|
2021
Q1 | $337K | Buy |
710
+596
| +523% | +$283K | 0.03% | 256 |
|
|
2020
Q4 | $201K | Buy |
+114
| New | +$201K | 0.02% | 306 |
|